Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-07-18 00:00:00 ET · period of report 2025-06-18 · accession 0001140361-25-026409 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-18 | 2025-06-18 | RCKT | Dolsten Mikael | Dir | A - Grant | $0.00 | +30.0K | 44.2K | +211% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-18 | A | A | 30,000 | $0.00 | 44,220 | D | — | — | (F1) Holdings include 14,220 restricted stock units ("RSUs") that convert to common stock on a one-for-one basis held by the Reporting Person which cliff vest on December 31, 2025. (F2) Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 18, 2026. |